Clinical Trial Update: MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MP0317 in combination with chemoimmunotherapy as first-line treatment for advanced biliary tract carcinoma is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• MP0317

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Advanced Biliary Tract Carcinoma | Phase 2 | Status: RECRUITING